The 12 closest competitors and alternatives to Primogene among biotechnology companies — ranked by similarity to what Primogene actually does, not by market-cap band.
Subscribe to see Primogene’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Primogene GmbH is a biotechnology startup founded in 2023 and based in Leipzig, Germany. Backed by venture funding, the company develops nature-inspired biological solutions and products.
Primogene is a biotechnology company headquartered in Germany. Its most recent funding round, Seed, raised $4.1M in April 2026. Xcout tracks 3 named people at Primogene, including Dr.-Ing. Reza Mahour (CEO and Co-founder).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $4.1M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Primogene by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Navigo Proteins GmbH is a biotechnology research company headquartered in Halle, Germany, specializing in precision protein engineering for life sciences. The firm develops engineered affinity proteins and tailored solutions for biopharmaceutical applications.
Life Sciences Consulting & Engineering
Prime Life Sciences is a biotechnology company specialized in pharmacy, biotechnology, and medical devices. Launched in 2020, it is headquartered in Basel, Switzerland, delivering targeted solutions across various healthcare sectors.
Similar biotechnology company
VITA 34 AG is dedicated to the collection, processing, and long-term storage of stem cells derived from umbilical cord blood and tissue. Its operations span Germany, Spain, and global markets. The company actively develops a range of advanced therapeutic solutions, including cell and gene therapies, specialized cell therapeutic procedures, cryopreservation of a patient's own immune cells, and CAR-T cell technology. Furthermore, VITA 34 manufactures advanced therapy medicinal products (ATMPs) based on mesenchymal stem cells for experimental applications by specialized medical institutions. It also preserves stem cells from perinatal tissues and adult body fat, and provides contract manufacturing for pharmaceutical intermediates. Founded in 1997, VITA 34 AG is headquartered in Leipzig, Germany.
Biotech
Epitome Therapeutics is an early-stage biotechnology company based in Vienna, Austria, founded in 2025 as a spin-off from EMBL Rome. It is developing a new therapeutic modality for precise and durable activation of endogenous genes.
Similar biotechnology company
Cocoon Biotech, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts. The company operates as a biotechnology firm focused on developing innovative biological solutions.
Similar biotechnology company
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Similar biotechnology company
Revier Therapeutics is a biotechnology company headquartered in Heidelberg, Germany, founded in 2023. The company closed a EUR 6 million seed financing round to advance its therapeutic pipeline and research operations.
Similar biotechnology company
Lenera is a next-generation biotechnology research company headquartered in Porto, Portugal. The firm operates with a small team focused on advanced biotech innovations.
Life Science
ActiTrexx GmbH is a biotechnology research company founded with a small team of employees. The company is headquartered in Mainz, Germany.
Similar biotechnology company
ChemT Biotechnology is an early-stage biotechnology research company headquartered in Singapore that develops commercial products and advanced bio-based solutions.
Similar biotechnology company
Kyron.bio is a Paris-based biotechnology startup using synthetic biology to refine biologic drug design and improve the yield, activity, and stability of new therapies.
Similar biotechnology company
Glycogene Inc. is an RNA raw material supply and product development company headquartered in Biolake, Wuhan Optics Valley, China. Founded in 2019 by experts in nucleic acids, glycoscience, and enzyme evolution, the company also operates research and development and commercial manufacturing facilities in Shenzhen and Qingdao.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Primogeneand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →